May 7, 2018 / 11:37 AM / 4 months ago

BRIEF-Auris Medical Receives Positive Scientific Advice From EMA On Development Plan And Regulatory Pathway For AM-111

May 7 (Reuters) - Auris Medical Holding AG:

* AURIS MEDICAL RECEIVES POSITIVE SCIENTIFIC ADVICE FROM EMA ON DEVELOPMENT PLAN AND REGULATORY PATHWAY FOR AM-111

* AURIS MEDICAL HOLDING AG - DESIGN FOR SINGLE PIVOTAL PHASE 3 TRIAL VALIDATED BY EUROPEAN MEDICINES AGENCY

* AURIS MEDICAL - INTENDS TO PROVIDE UPDATE ON PLANS FOR ADVANCING AM-111 DEVELOPMENT PROGRAM AS PART OF A GENERAL STRATEGY UPDATE ON MAY 15 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below